Royalty Pharma (NASDAQ:RPRX) Is Due To Pay A Dividend Of $0.21
Express News | Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024
Royalty Pharma To Go Ex-Dividend On August 16th, 2024 With 0.21 USD Dividend Per Share
Trending Stocks Today | Discover Financial Services up 4.59% Post-Market
Royalty Pharma Keeps Quarterly Dividend at $0.21 Per Share, Payable Sept. 13 to Shareholders of Record Aug. 16
Press Release: Royalty Pharma Declares Third Quarter 2024 Dividend
Royalty Pharma (RPRX) Recently Broke Out Above the 50-Day Moving Average
Will Royalty Pharma (RPRX) Beat Estimates Again in Its Next Earnings Report?
Royalty Pharma Price Target Raised to $51.00/Share From $48.00 by Morgan Stanley
Morgan Stanley Maintains Royalty Pharma(RPRX.US) With Buy Rating, Raises Target Price to $51
Morgan Stanley Sticks to Its Buy Rating for Royalty Pharma (RPRX)
Royalty Pharma Plc (NASDAQ:RPRX) Is Largely Controlled by Institutional Shareholders Who Own 70% of the Company
Express News | Royalty Pharma: PTC Therapeutics Exercised Option to Sell Half of Retained Royalties on Roche's Evrysdi to Co's Unit for About $242 Mln Upfront
Declining Stock and Decent Financials: Is The Market Wrong About Royalty Pharma Plc (NASDAQ:RPRX)?
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Goldman Sachs Maintains Royalty Pharma(RPRX.US) With Buy Rating, Maintains Target Price $50
Express News | Royalty Pharma:To Issue, Sell to Underwriters $500 Mln of Its 5.400% Senior Notes Due 2034 & $500 Mln of Its 5.900% Senior Notes Due 2059 in Offering
Express News | Royalty Pharma-on June 3,Entered Into Underwriting Deal, Co to Issue & Sell to Underwriters $500 Mln Amount of Its 5.150% Senior Notes Due 2029
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Express News | Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes